<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03015116</url>
  </required_header>
  <id_info>
    <org_study_id>M-10548</org_study_id>
    <nct_id>NCT03015116</nct_id>
  </id_info>
  <brief_title>Photobiomodulation for Plantar Fasciitis</brief_title>
  <official_title>Effectiveness of Photobiomodulation Compared to Usual Care for Plantar Fasciitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Landstuhl Regional Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Landstuhl Regional Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      BACKGROUND: Plantar fasciitis, a degenerative injury of the connective tissue in the foot,&#xD;
      results in pain-related disability in Service Members and beneficiaries and contributes to&#xD;
      decreased physical activity and excessive healthcare costs. Even if effective, current&#xD;
      treatment protocols may require 6-12 months of therapy to return individuals to pain-free&#xD;
      activity. Photobiomodulation (PBM), or low level laser therapy, uses non-ionizing light to&#xD;
      elicit biological changes in tissues resulting in beneficial therapeutic outcomes. Evidence&#xD;
      supports use of PBM for other degenerative connective tissue conditions, such as Achilles&#xD;
      tendinopathy and epicondylitis. Unfortunately, previous studies of PBM for treatment of&#xD;
      plantar fasciitis lack optimized treatment parameters and therefore have been inconclusive on&#xD;
      its clinical effectiveness.&#xD;
&#xD;
      SPECIFIC AIMS: 1. Establish feasibility of and adherence to a photobiomodulation protocol in&#xD;
      conjunction with and compared to usual care for plantar fasciitis treatment. 2. Assess the&#xD;
      clinical effectiveness of photobiomodulation in conjunction with and compared to usual care&#xD;
      to improve function and decrease pain and in patients. 3. Assess the difference between two&#xD;
      photobiomodulation dose parameters in conjunction with and compared to usual care for plantar&#xD;
      fasciitis treatment.&#xD;
&#xD;
      DESIGN: The investigators will use a prospective randomized controlled trial to meet the aims&#xD;
      of this exploratory study. METHOD: A sample of 114 military healthcare beneficiaries will be&#xD;
      randomly assigned to either usual care, usual care plus PBM lower dose, or usual care plus&#xD;
      PBM higher dose groups. At baseline, during the treatment protocol, and at long term (3 and 6&#xD;
      month) follow-up, measures of foot function and pain will be collected for analysis. The&#xD;
      proposed methods will allow the study team to establish if PBM accelerates recovery compared&#xD;
      to usual care, as well as determining the optimal dose for future trials comparing PBM to&#xD;
      other, more invasive, therapies for plantar fasciitis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 12, 2017</start_date>
  <completion_date type="Actual">February 28, 2020</completion_date>
  <primary_completion_date type="Actual">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Foot and Ankle Ability Measure (FAAM)</measure>
    <time_frame>Baseline, 3 weeks, and 6 weeks</time_frame>
    <description>The FAAM is a 29-item self-report instrument that assesses physical function in foot and ankle impairments which included plantar fasciitis cases in development. There are two subscales, Activities of Daily Living (21-item) and Sports (8-item). Each item is scored on a 5-point Likert scale (4='no difficulty at all' to 0='unable to do'); points are transformed to a percentage (100%=no dysfunction). A higher score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defense and Veterans Pain Rating Scale (DVPRS)</measure>
    <time_frame>Baseline, 3 weeks, and 6 weeks</time_frame>
    <description>Defense and Veterans Pain Rating Scale (DVPRS). This 5-item scale integrates a numeric pain rating scale with visual facial cues and word descriptors as well as 4 supplemental questions on pain interference. Each item is scores 0-10 with higher scores indicating worse pain/interference. Lower scores mean a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Foot and Ankle Ability Measure (FAAM) Long-term</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>The FAAM is a 29-item self-report instrument that assesses physical function in foot and ankle impairments which included plantar fasciitis cases in development. There are two subscales, Activities of Daily Living (21-item) and Sports (8-item). Each item is scored on a 5-point Likert scale (4='no difficulty at all' to 0='unable to do'); points are transformed to a percentage (100%=no dysfunction). A higher score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Defense and Veterans Pain Rating Scale (DVPRS) Long-term</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Defense and Veterans Pain Rating Scale (DVPRS). This 5-item scale integrates a numeric pain rating scale with visual facial cues and word descriptors as well as 4 supplemental questions on pain interference. Each item is scores 0-10 with higher scores indicating worse pain/interference. Lower scores mean a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ankle Dorsiflexion</measure>
    <time_frame>% change from baseline to 3 weeks, % change from 3 weeks to 6 weeks, % change from baseline to 6 weeks</time_frame>
    <description>Measures range of motion of ankle in weight-bearing conditions; recorded as distance from great toe to wall at maximal dorsiflexion in centimeters. The percentage of change between timepoints will be calculated for each individual and then compiled per group.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Plantar Fascitis</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will complete 6 weeks of stretching and cryotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PBM 10 Watts</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PBM 25 Watts</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stretching</intervention_name>
    <description>Daily foot and ankle stretching protocol</description>
    <arm_group_label>PBM 10 Watts</arm_group_label>
    <arm_group_label>PBM 25 Watts</arm_group_label>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cryotherapy</intervention_name>
    <description>Daily cryotherapy in conjunction with stretching</description>
    <arm_group_label>PBM 10 Watts</arm_group_label>
    <arm_group_label>PBM 25 Watts</arm_group_label>
    <arm_group_label>Usual Care</arm_group_label>
    <other_name>Ice</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Photobiomodulation Low Power</intervention_name>
    <description>Photobiomodulation treatment with 10W power output</description>
    <arm_group_label>PBM 10 Watts</arm_group_label>
    <other_name>Low Level Laser therapy</other_name>
    <other_name>low level light therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Photobiomodulation High Power</intervention_name>
    <description>Photobiomodulation treatment with 25W power output</description>
    <arm_group_label>PBM 25 Watts</arm_group_label>
    <other_name>Low level laser therapy</other_name>
    <other_name>low level light therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Between ages of 18 - 65 years&#xD;
&#xD;
          2. Eligible for care at Landstuhl Regional Medical Center&#xD;
&#xD;
          3. Diagnosis of PF by healthcare provider based on accepted diagnostic criteria&#xD;
&#xD;
          4. Have experienced symptoms of PF for at least 3 months&#xD;
&#xD;
          5. Able to read and understand English language for consent purposes&#xD;
&#xD;
          6. Able to commit to 6 week intervention and 3 and 6 month follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or plan on becoming pregnant during intervention period (Safety of PBM not&#xD;
             established in pregnancy)&#xD;
&#xD;
          2. History of traumatic injury to symptomatic foot/feet&#xD;
&#xD;
          3. Diagnosis of calcaneal fracture&#xD;
&#xD;
          4. Have previously had corticosteroid injections, surgery, or other invasive treatment&#xD;
             for same condition&#xD;
&#xD;
          5. Greater than 15% of calf area covered in tattoos/ink/scarring (Pigment in ink can&#xD;
             absorb light, causing overheating of skin)&#xD;
&#xD;
          6. History of neuropathy or unable to detect changes in skin temperature (increased risk&#xD;
             of skin warming due to inability to detect change)&#xD;
&#xD;
          7. Currently using medications associated with sensitivity to heat or light (e.g.&#xD;
             amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid,&#xD;
             naproxen, piroxicam, tetracycline, thioridazine, voriconazole)(8) Concurrent&#xD;
             participation in another research study addressing pain issue&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ann K Ketz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LRMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Landstuhl Regional Medical Center</name>
      <address>
        <city>Landstuhl</city>
        <state>APO Ae</state>
        <zip>09180</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 4, 2017</study_first_submitted>
  <study_first_submitted_qc>January 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2017</study_first_posted>
  <results_first_submitted>February 10, 2020</results_first_submitted>
  <results_first_submitted_qc>September 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 21, 2021</results_first_posted>
  <last_update_submitted>September 18, 2021</last_update_submitted>
  <last_update_submitted_qc>September 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Landstuhl Regional Medical Center</investigator_affiliation>
    <investigator_full_name>Ann Ketz</investigator_full_name>
    <investigator_title>Chief, Center for Nursing Science and Clinical Inquiry</investigator_title>
  </responsible_party>
  <keyword>photobiomodulation</keyword>
  <keyword>plantar fasciitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 8, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT03015116/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 16, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT03015116/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching</description>
        </group>
        <group group_id="P2">
          <title>PBM 10 Watts</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
        </group>
        <group group_id="P3">
          <title>PBM 25 Watts</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="36"/>
                <participants group_id="P3" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject has New Medical Status</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching</description>
        </group>
        <group group_id="B2">
          <title>PBM 10 Watts</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
        </group>
        <group group_id="B3">
          <title>PBM 25 Watts</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="38"/>
            <count group_id="B4" value="114"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="113"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African-American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic/Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian/Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Underweight (Less than 18.5)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Normal Weight (18.5 - 24.9)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Overweight (25-29.9)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="57"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Obese (Greater than or Equal to 30.0)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Months with Plantar Fasciitis or Plantar Heel Pain</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>0 to 6 Months</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>7 to 12 Months</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>13 to 24 Months</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Greater than 24 months</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Missing Data</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fitzpatrick Skin Type</title>
          <description>A numerical schema for skin color based on melanin pigment, which participants self-select. There is no inherent value to the numbers. 1- skin ivory, always freckles, always burns/peels, never tans; 2 - skin fair or pale, usually freckles, burns/peels often, rarely tans; 3 - skin fair to beige, might freckle, burns on occasion, sometimes tans; 4 - skin olive or light brown, doesn't really freckle, burns rarely, tans often; 5 - skin dark brown, rarely freckles, almost never burns, always tans; 6 - skin deeply pigmented dark brown, never freckles, never burns, always tans darkly.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Type I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type V</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Type VI</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Missing Data</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Foot and Ankle Ability Measure (FAAM)</title>
        <description>The FAAM is a 29-item self-report instrument that assesses physical function in foot and ankle impairments which included plantar fasciitis cases in development. There are two subscales, Activities of Daily Living (21-item) and Sports (8-item). Each item is scored on a 5-point Likert scale (4='no difficulty at all' to 0='unable to do'); points are transformed to a percentage (100%=no dysfunction). A higher score means a better outcome.</description>
        <time_frame>Baseline, 3 weeks, and 6 weeks</time_frame>
        <population>7 withdrew from Usual Care group; 2 each from treatment groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching</description>
          </group>
          <group group_id="O2">
            <title>PBM 10 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
          </group>
          <group group_id="O3">
            <title>PBM 25 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
          </group>
        </group_list>
        <measure>
          <title>Foot and Ankle Ability Measure (FAAM)</title>
          <description>The FAAM is a 29-item self-report instrument that assesses physical function in foot and ankle impairments which included plantar fasciitis cases in development. There are two subscales, Activities of Daily Living (21-item) and Sports (8-item). Each item is scored on a 5-point Likert scale (4='no difficulty at all' to 0='unable to do'); points are transformed to a percentage (100%=no dysfunction). A higher score means a better outcome.</description>
          <population>7 withdrew from Usual Care group; 2 each from treatment groups.</population>
          <units>percentage of total score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline ADL Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.2" lower_limit="61.2" upper_limit="71.2"/>
                    <measurement group_id="O2" value="72.4" lower_limit="67.3" upper_limit="77.4"/>
                    <measurement group_id="O3" value="69.9" lower_limit="64.8" upper_limit="74.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 ADL Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.3" lower_limit="63.9" upper_limit="74.9"/>
                    <measurement group_id="O2" value="81.4" lower_limit="76.2" upper_limit="86.5"/>
                    <measurement group_id="O3" value="78.5" lower_limit="73.4" upper_limit="83.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 ADL Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.4" lower_limit="65.1" upper_limit="75.7"/>
                    <measurement group_id="O2" value="82.9" lower_limit="77.7" upper_limit="88.0"/>
                    <measurement group_id="O3" value="82.3" lower_limit="77.2" upper_limit="87.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Sports Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.4" lower_limit="39.4" upper_limit="53.3"/>
                    <measurement group_id="O2" value="46.5" lower_limit="39.5" upper_limit="53.5"/>
                    <measurement group_id="O3" value="46.3" lower_limit="39.3" upper_limit="53.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Sports Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.6" lower_limit="39.2" upper_limit="54.0"/>
                    <measurement group_id="O2" value="62.4" lower_limit="55.3" upper_limit="69.5"/>
                    <measurement group_id="O3" value="62.0" lower_limit="55.1" upper_limit="68.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Sports Subscale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.9" lower_limit="46.6" upper_limit="61.1"/>
                    <measurement group_id="O2" value="67.7" lower_limit="60.6" upper_limit="74.4"/>
                    <measurement group_id="O3" value="65.7" lower_limit="58.7" upper_limit="72.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Defense and Veterans Pain Rating Scale (DVPRS)</title>
        <description>Defense and Veterans Pain Rating Scale (DVPRS). This 5-item scale integrates a numeric pain rating scale with visual facial cues and word descriptors as well as 4 supplemental questions on pain interference. Each item is scores 0-10 with higher scores indicating worse pain/interference. Lower scores mean a better outcome.</description>
        <time_frame>Baseline, 3 weeks, and 6 weeks</time_frame>
        <population>7 withdrew from Usual Care group; 2 each from treatment groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching</description>
          </group>
          <group group_id="O2">
            <title>PBM 10 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
          </group>
          <group group_id="O3">
            <title>PBM 25 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
          </group>
        </group_list>
        <measure>
          <title>Defense and Veterans Pain Rating Scale (DVPRS)</title>
          <description>Defense and Veterans Pain Rating Scale (DVPRS). This 5-item scale integrates a numeric pain rating scale with visual facial cues and word descriptors as well as 4 supplemental questions on pain interference. Each item is scores 0-10 with higher scores indicating worse pain/interference. Lower scores mean a better outcome.</description>
          <population>7 withdrew from Usual Care group; 2 each from treatment groups.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline 24 Hour Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.031" lower_limit="3.215" upper_limit="4.848"/>
                    <measurement group_id="O2" value="4.146" lower_limit="3.505" upper_limit="4.786"/>
                    <measurement group_id="O3" value="3.763" lower_limit="3.110" upper_limit="4.415"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 24 Hour Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.634" lower_limit="2.658" upper_limit="4.610"/>
                    <measurement group_id="O2" value="2.948" lower_limit="2.182" upper_limit="3.714"/>
                    <measurement group_id="O3" value="2.863" lower_limit="2.082" upper_limit="3.644"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 24 Hour Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.652" lower_limit="2.695" upper_limit="6.608"/>
                    <measurement group_id="O2" value="2.61" lower_limit="1.859" upper_limit="3.360"/>
                    <measurement group_id="O3" value="2.943" lower_limit="2.178" upper_limit="3.708"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Activity Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.462" lower_limit="2.516" upper_limit="4.408"/>
                    <measurement group_id="O2" value="3.869" lower_limit="3.169" upper_limit="4.570"/>
                    <measurement group_id="O3" value="3.798" lower_limit="3.018" upper_limit="4.578"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Activity Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.513" lower_limit="2.522" upper_limit="4.503"/>
                    <measurement group_id="O2" value="2.696" lower_limit="1.962" upper_limit="3.430"/>
                    <measurement group_id="O3" value="2.777" lower_limit="1.960" upper_limit="3.594"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Activity Interferece</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.555" lower_limit="2.608" upper_limit="4.501"/>
                    <measurement group_id="O2" value="2.244" lower_limit="1.543" upper_limit="2.945"/>
                    <measurement group_id="O3" value="2.736" lower_limit="1.955" upper_limit="3.516"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Sleep Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.857" lower_limit="0.966" upper_limit="2.748"/>
                    <measurement group_id="O2" value="2.548" lower_limit="1.888" upper_limit="3.207"/>
                    <measurement group_id="O3" value="1.667" lower_limit="0.932" upper_limit="2.401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Sleep Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.269" lower_limit="1.336" upper_limit="3.202"/>
                    <measurement group_id="O2" value="1.986" lower_limit="1.296" upper_limit="2.677"/>
                    <measurement group_id="O3" value="1.229" lower_limit="0.460" upper_limit="1.998"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Sleep Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.748" lower_limit="0.900" upper_limit="2.596"/>
                    <measurement group_id="O2" value="1.476" lower_limit="0.848" upper_limit="2.104"/>
                    <measurement group_id="O3" value="1.111" lower_limit="0.412" upper_limit="1.811"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Mood Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.496" lower_limit="1.577" upper_limit="3.414"/>
                    <measurement group_id="O2" value="2.363" lower_limit="1.682" upper_limit="3.043"/>
                    <measurement group_id="O3" value="2.164" lower_limit="1.406" upper_limit="2.921"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Mood Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.630" lower_limit="1.662" upper_limit="3.599"/>
                    <measurement group_id="O2" value="1.530" lower_limit="0.813" upper_limit="2.247"/>
                    <measurement group_id="O3" value="1.589" lower_limit="0.790" upper_limit="2.387"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Mood Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.092" lower_limit="1.212" upper_limit="2.973"/>
                    <measurement group_id="O2" value="1.125" lower_limit="0.473" upper_limit="1.777"/>
                    <measurement group_id="O3" value="1.486" lower_limit="0.760" upper_limit="2.211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline Stress Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.471" lower_limit="1.489" upper_limit="3.462"/>
                    <measurement group_id="O2" value="2.358" lower_limit="1.631" upper_limit="3.085"/>
                    <measurement group_id="O3" value="2.215" lower_limit="1.406" upper_limit="3.024"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 Stress Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.504" lower_limit="1.534" upper_limit="3.475"/>
                    <measurement group_id="O2" value="1.433" lower_limit="0.770" upper_limit="2.207"/>
                    <measurement group_id="O3" value="1.646" lower_limit="0.846" upper_limit="2.446"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 6 Stress Interference</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.345" lower_limit="1.441" upper_limit="3.248"/>
                    <measurement group_id="O2" value="1.031" lower_limit="0.62" upper_limit="1.699"/>
                    <measurement group_id="O3" value="1.450" lower_limit="0.705" upper_limit="2.195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Foot and Ankle Ability Measure (FAAM) Long-term</title>
        <description>The FAAM is a 29-item self-report instrument that assesses physical function in foot and ankle impairments which included plantar fasciitis cases in development. There are two subscales, Activities of Daily Living (21-item) and Sports (8-item). Each item is scored on a 5-point Likert scale (4='no difficulty at all' to 0='unable to do'); points are transformed to a percentage (100%=no dysfunction). A higher score means a better outcome.</description>
        <time_frame>3 months and 6 months</time_frame>
        <population>Individuals were lost to follow up at each long term follow up time point. Participants from the UC group completed the study after the 6 week follow-up time point. No data were collected from UC care group for the 3 and 6 month time points, therefore are not included in the 3 and 6 month measures.</population>
        <group_list>
          <group group_id="O1">
            <title>PBM 10 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
          </group>
          <group group_id="O2">
            <title>PBM 25 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
          </group>
        </group_list>
        <measure>
          <title>Foot and Ankle Ability Measure (FAAM) Long-term</title>
          <description>The FAAM is a 29-item self-report instrument that assesses physical function in foot and ankle impairments which included plantar fasciitis cases in development. There are two subscales, Activities of Daily Living (21-item) and Sports (8-item). Each item is scored on a 5-point Likert scale (4='no difficulty at all' to 0='unable to do'); points are transformed to a percentage (100%=no dysfunction). A higher score means a better outcome.</description>
          <population>Individuals were lost to follow up at each long term follow up time point. Participants from the UC group completed the study after the 6 week follow-up time point. No data were collected from UC care group for the 3 and 6 month time points, therefore are not included in the 3 and 6 month measures.</population>
          <units>percentage of total score</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 Months ADL Subscale</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.3" lower_limit="74.6" upper_limit="85.9"/>
                    <measurement group_id="O2" value="81.5" lower_limit="76.1" upper_limit="86.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Sports Subscale</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.4" lower_limit="53.9" upper_limit="70.9"/>
                    <measurement group_id="O2" value="67.6" lower_limit="59.6" upper_limit="75.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months ADL Subscale</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.0" lower_limit="76.1" upper_limit="87.9"/>
                    <measurement group_id="O2" value="82.2" lower_limit="76.7" upper_limit="87.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Sports Subscale</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.4" lower_limit="56.5" upper_limit="74.3"/>
                    <measurement group_id="O2" value="69.0" lower_limit="60.6" upper_limit="77.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Defense and Veterans Pain Rating Scale (DVPRS) Long-term</title>
        <description>Defense and Veterans Pain Rating Scale (DVPRS). This 5-item scale integrates a numeric pain rating scale with visual facial cues and word descriptors as well as 4 supplemental questions on pain interference. Each item is scores 0-10 with higher scores indicating worse pain/interference. Lower scores mean a better outcome.</description>
        <time_frame>3 months and 6 months</time_frame>
        <population>Individuals were lost to follow up at each long term follow up time point. Participants from the UC group completed the study after the 6 week follow-up time point. No data were collected from UC care group for the 3 and 6 month time points, therefore are not included in the 3 and 6 month measures.</population>
        <group_list>
          <group group_id="O1">
            <title>PBM 10 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
          </group>
          <group group_id="O2">
            <title>PBM 25 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
          </group>
        </group_list>
        <measure>
          <title>Defense and Veterans Pain Rating Scale (DVPRS) Long-term</title>
          <description>Defense and Veterans Pain Rating Scale (DVPRS). This 5-item scale integrates a numeric pain rating scale with visual facial cues and word descriptors as well as 4 supplemental questions on pain interference. Each item is scores 0-10 with higher scores indicating worse pain/interference. Lower scores mean a better outcome.</description>
          <population>Individuals were lost to follow up at each long term follow up time point. Participants from the UC group completed the study after the 6 week follow-up time point. No data were collected from UC care group for the 3 and 6 month time points, therefore are not included in the 3 and 6 month measures.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Month 3 24 Hour Pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.449" lower_limit="1.688" upper_limit="3.211"/>
                    <measurement group_id="O2" value="1.977" lower_limit="1.315" upper_limit="2.639"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 24 Hour Pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.126" lower_limit="1.350" upper_limit="2.901"/>
                    <measurement group_id="O2" value="2.148" lower_limit="1.450" upper_limit="2.847"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Activity Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.583" lower_limit="1.828" upper_limit="3.337"/>
                    <measurement group_id="O2" value="1.995" lower_limit="1.286" upper_limit="2.704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Activity Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.326" lower_limit="1.540" upper_limit="3.113"/>
                    <measurement group_id="O2" value="1.818" lower_limit="1.094" upper_limit="2.542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Sleep Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.691" lower_limit="0.974" upper_limit="2.409"/>
                    <measurement group_id="O2" value="0.720" lower_limit="0.146" upper_limit="1.294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Sleep Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.541" lower_limit="0.796" upper_limit="2.287"/>
                    <measurement group_id="O2" value="0.880" lower_limit="0.149" upper_limit="1.294"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Mood Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.770" lower_limit="1.094" upper_limit="2.445"/>
                    <measurement group_id="O2" value="1.034" lower_limit="0.399" upper_limit="1.669"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Mood Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.614" lower_limit="0.910" upper_limit="2.317"/>
                    <measurement group_id="O2" value="1.157" lower_limit="0.509" upper_limit="1.805"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3 Stress Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="28"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.174" lower_limit="0.484" upper_limit="1.864"/>
                    <measurement group_id="O2" value="1.040" lower_limit="0.378" upper_limit="1.702"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6 Stress Interference</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="25"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.391" lower_limit="0.579" upper_limit="2.204"/>
                    <measurement group_id="O2" value="1.040" lower_limit="0.261" upper_limit="1.819"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ankle Dorsiflexion</title>
        <description>Measures range of motion of ankle in weight-bearing conditions; recorded as distance from great toe to wall at maximal dorsiflexion in centimeters. The percentage of change between timepoints will be calculated for each individual and then compiled per group.</description>
        <time_frame>% change from baseline to 3 weeks, % change from 3 weeks to 6 weeks, % change from baseline to 6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching</description>
          </group>
          <group group_id="O2">
            <title>PBM 10 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
          </group>
          <group group_id="O3">
            <title>PBM 25 Watts</title>
            <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
          </group>
        </group_list>
        <measure>
          <title>Ankle Dorsiflexion</title>
          <description>Measures range of motion of ankle in weight-bearing conditions; recorded as distance from great toe to wall at maximal dorsiflexion in centimeters. The percentage of change between timepoints will be calculated for each individual and then compiled per group.</description>
          <units>percentage of change over time</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>% Change baseline to 3 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.14" spread="0.029"/>
                    <measurement group_id="O2" value="7.16" spread="0.036"/>
                    <measurement group_id="O3" value="17.24" spread="0.045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% change week 3 to week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.03" spread="0.037"/>
                    <measurement group_id="O2" value="9.02" spread="0.047"/>
                    <measurement group_id="O3" value="3.86" spread="0.023"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>% change baseline to week 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.6" spread="0.055"/>
                    <measurement group_id="O2" value="13.22" spread="0.043"/>
                    <measurement group_id="O3" value="19.79" spread="0.045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected during the six weeks of active study treatment.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching</description>
        </group>
        <group group_id="E2">
          <title>PBM 10 Watts</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 10 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation Low Power: Photobiomodulation treatment with 10W power output</description>
        </group>
        <group group_id="E3">
          <title>PBM 25 Watts</title>
          <description>Participants will complete 6 weeks of stretching and cryotherapy, plus 9 treatments of PBM (810/980 nm continuous wave, 25 Watts power) over 3 weeks&#xD;
Stretching: Daily foot and ankle stretching protocol&#xD;
Cryotherapy: Daily cryotherapy in conjunction with stretching&#xD;
Photobiomodulation High Power: Photobiomodulation treatment with 25W power output</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>CTCAE (4.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Numbness and Tingling</sub_title>
                <description>Grade 2, probably not related to treatment</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No sham group to neutralize bias related to intervention; Not able to compare the usual care group to the intervention group in long term follow up.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Ann Kobiela Ketz</name_or_title>
      <organization>Landstuhl Regional Medical Center</organization>
      <phone>8022656263</phone>
      <email>annketz@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

